Abstract:Stimuli-responsive cross-linked micelles (SCMs) are ideal nanocarriers for anti-cancer drugs. Compared with non-cross-linked micelles, SCMs exhibit superior structural stability. At the same time, the introduction of an environmentally sensitive crosslinker into a drug delivery system allows SCMs to respond to single or multiple stimuli in the tumor microenvironment, which can minimize drug leakage during the blood circulation process. In this study, curcumin (CUR) was modified as the hydrophobic core crosslinker by utilizing the bisphenol structure, and redox sensitive disulfide bonds were introduced to prepare the glutathione (GSH) stimulated responsive core crosslinker (abbreviated as N3-ss-CUR-ss-N3). In addition, amphiphilic polymer APEG-b-PBYP was prepared through the ring opening reaction, and reacted with the crosslinker through the "click" reaction. After being dispersed in the aqueous phase, core cross-linked nanoparticles (CCL NPs) were obtained. Finally, monoclonal antibody CD326 (mAb-CD326) was reduced and coupled to the hydrophilic chain ends to obtain the nanoparticles with surface modified antibodies (R-mAb-CD326@CCL NPs) for further enhancing targeted drug delivery. The structures of the polymer and crosslinker were characterized by 1H NMR, UV-Vis, FT-IR, and GPC. The morphology, size and stability of CCL NPs and R-mAb-CD326@CCL NPs were investigated by DLS and TEM. The in vitro drug release behavior of CCL NPs was also studied. The results showed that the CCL NPs exhibited reduction-responsiveness and were able to release the original drug CUR under 10 mM GSH conditions. Additionally, the CCL NPs exhibited excellent stability in both the simulated body fluid environment and organic solvents. Especially, R-mAb-CD326@CCL NPs can actively target tumor cells and showed better therapeutic efficacy in in vivo experiments with a tumor suppression rate of 78.7%. This work provides a new idea for the design of nano-drugs targeting breast cancer.

Development of Rgd-Functionalized Peg-Pla Micelles for Delivery of Curcumin

Discovery And In Vivo Evaluation Of Novel Rgd-Modified Lipid-Polymer Hybrid Nanoparticles For Targeted Drug Delivery

Development of a folate-modified curcumin loaded micelle delivery system for cancer targeting

Novel Amphiphilic Rhamnogalacturonnan I-based Nanomicelles for Targeted Delivery of Curcumin to Hepatocellular Carcinoma Cells

Copolymeric Micelles Loading Curcumin: Preparation, Characterization and In Vitro Evaluation.

Preparation and evaluation of the anti-cancer properties of RGD-modified curcumin-loaded chitosan/perfluorohexane nanocapsules in vitro

Polymeric Micelles for Parenteral Delivery of Curcumin: Preparation, Characterization and in Vitro Evaluation

Improving the Anti-Colon Cancer Activity of Curcumin with Biodegradable Nano-Micelles.

Improving Antiangiogenesis and Anti-Tumor Activity of Curcumin by Biodegradable Polymeric Micelles.

Enhancing Curcumin Anticancer Efficacy Through Di-Block Copolymer Micelle Encapsulation

Biodegradable Micelles Enhance The Antiglioma Activity Of Curcumin In Vitro And In Vivo

The Anti-Tumor Efficacy of Curcumin when Delivered by Size/charge-Changing Multistage Polymeric Micelles Based on Amphiphilic Poly(β-Amino Ester) Derivates

Linear-Dendrimer Type Methoxy-Poly (Ethylene Glycol)-B-Poly (Epsilon-Caprolactone) Copolymer Micelles For The Delivery Of Curcumin

Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo.

A CD326 monoclonal antibody modified core cross-linked curcumin-polyphosphoester prodrug for targeted delivery and cancer treatment

Curcumin-Encapsulated Polymeric Micelles Suppress the Development of Colon Cancer In Vitro and In Vivo

Elaboration and Characterization of Curcumin-Loaded Tri-CL-mPEG Three-Arm Copolymeric Nanoparticles by a Microchannel Technology

Multifunctional β-Cyclodextrin-Poly(ethylene glycol)-Cholesterol Nanomicelle for Anticancer Drug Delivery

Curcumin-Loaded Blood-Stable Polymeric Micelles for Enhancing Therapeutic Effect on Erythroleukemia

Ph-Sensitive Micelles Based on Acid-Labile Pluronic F68–curcumin Conjugates for Improved Tumor Intracellular Drug Delivery

Y-shaped Biotin-Conjugated Poly (ethylene Glycol)-Poly (Epsilon-Caprolactone) Copolymer for the Targeted Delivery of Curcumin.